Ecolab (ECL)
(Delayed Data from NYSE)
$253.55 USD
-1.78 (-0.70%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $253.42 -0.13 (-0.05%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$253.55 USD
-1.78 (-0.70%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $253.42 -0.13 (-0.05%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Zacks News
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
by Zacks Equity Research
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
FMC Corp (FMC) Teams Up With AgroSpheres for Bioinsecticides
by Zacks Equity Research
FMC partners with AgroSpheres to accelerate the development of innovative bioinsecticides, enhancing sustainable crop protection and reinforcing FMC's industry leadership.
Air Products (APD) Unveils PRISM LNG Membrane Separator
by Zacks Equity Research
Air Products' (APD) Membrane Solutions specializes in hollow fiber membrane separators and onsite gas generation.
DuPont (DD) to Showcase Advanced Circuit Materials in Shanghai
by Zacks Equity Research
The new technology solutions highlight DuPont's (DD) capacity to generate innovation and provide value in collaboration with industry leaders in the Artificial Intelligence field.
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
Three Reasons to Retain Integer Holdings (ITGR) Stock for Now
by Zacks Equity Research
Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials
by Zacks Equity Research
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
by Zacks Equity Research
Orthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to aid in curing fractures or abnormalities in individuals with osteogenesis imperfecta.
DuPont (DD) Introduces Tyvek Trifecta Breather Membrane
by Zacks Equity Research
DuPont (DD) Tyvek Trifecta complements the DuPont AirGuard A2 FR AVCL, resulting in a comprehensive A-rated membrane system.
Neogen (NEOG) Faces Macroeconomic Issues, Fierce Competition
by Zacks Equity Research
Neogen (NEOG) faces intense competition from companies ranging from small businesses to divisions of large multinational companies.
PacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up
by Zacks Equity Research
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.
LyondellBasell (LYB) Announces Review of European Operations
by Zacks Equity Research
LyondellBasell (LYB) is conducting a strategic review of its European operations, focusing on reinvesting in high-return businesses.
Air Products (APD) AP-DMR LNG Process Passes Performance Test
by Zacks Equity Research
Air Products' (APD) innovative AP-DMR LNG Process was chosen for its high efficiency, dependable operation and small footprint.
QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall
by Zacks Equity Research
QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.
Ashland (ASH) to Divest Nutraceuticals Business to Turnspire
by Zacks Equity Research
Ashland (ASH) is set to sell its nutraceuticals business to Turnspire Capital Partners, with the deal expected to close in third-quarter 2024.
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
OPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.
Should You Invest in the Invesco Water Resources ETF (PHO)?
by Zacks Equity Research
Sector ETF report for PHO
McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
Nevro's (NVRO) Q1 Earnings and Sales Beat Estimates, Margins Up
by Zacks Equity Research
Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.
Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up
by Zacks Equity Research
Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.
Fresenius Medical (FMS) Q1 Earnings Beat, Operating Margin Up
by Zacks Equity Research
Fresenius Medical's (FMS) first-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.
Barrick (GOLD) Announces Partnership With Geophysx Jamaica
by Zacks Equity Research
The agreement initially grants Barrick (GOLD) access to about 4,000 square kilometers of consolidated land positions across the country.
DOW to Sell Flexible Packaging Laminating Adhesives Business
by Zacks Equity Research
This deal allows DOW to focus even more on core, high-value downstream operations.
Are You Looking for a Top Momentum Pick? Why Ecolab (ECL) is a Great Choice
by Zacks Equity Research
Does Ecolab (ECL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
by Zacks Equity Research
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.